CHD4 and epilepsy: In the five clinical‐genetic dimensional evaluation, evidence from four of the five clinical‐genetic aspects (repetition, genotype‐phenotype correlation, inheritance pattern, and molecular sub‐regional implications) was ranked “Yes,” suggesting that epilepsy was a novel phenotype of CHD4 variants (Table S4).